| Authors: |
Thanarajasingam G; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA., Kluetz PG; U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Bhatnagar V; U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Brown A; Health Education and Content Services, Mayo Clinic, Rochester, Minnesota, USA., Cathcart-Rake E; Department of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA., Diamond M; U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Faust L; Division of Health Care Delivery Research, Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA., Fiero MH; U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Huntington SF; Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.; Yale's Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale School of Medicine, New Haven, Connecticut, USA., Jeffery MM; Division of Health Care Delivery Research, Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA.; Department of Emergency Medicine, Mayo Clinic, Rochester, Minnesota, USA., Jones L; Patient advocate, Arlington, Virginia, USA., Noble BN; Department of Quantitative Health Sciences, Mayo Clinic, Phoenix, Arizona, USA., Paludo J; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA., Powers B; CancerHacker Lab, Boston, Massachusetts, USA., Ross JS; Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.; Yale-New Haven Center for Outcomes Research and Evaluation (CORE), New Haven, Connecticut, USA.; Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut, USA., Ritchie JD; Yale-New Haven Center for Outcomes Research and Evaluation (CORE), New Haven, Connecticut, USA., Ruddy KJ; Department of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA., Schellhorn SE; Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.; Yale's Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale School of Medicine, New Haven, Connecticut, USA., Tarver ME; U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Dueck AC; Department of Quantitative Health Sciences, Mayo Clinic, Phoenix, Arizona, USA., Gross CP; Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.; Yale's Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale School of Medicine, New Haven, Connecticut, USA.; Yale-New Haven Center for Outcomes Research and Evaluation (CORE), New Haven, Connecticut, USA.; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut, USA. |
